Abstract
A number of studies reported that miR-224-5p is involved in a variety of cancer-related cellular processes, yet its physiological role in clear cell renal cell carcinoma (ccRCC) remains unclear. In order to clarify the function of miR-224-5p in ccRCC, real-time quantitative-PCR was conducted to compare the expression of miR-224-5p in human normal renal tubular epithelial cell lines and ccRCC cell lines first, and a strikingly upregulated expression was observed in ccRCC cell lines. Inhibition of miR-224-5p expression by microRNA inhibitors could inhibit the proliferation, migration, and invasion of ccRCC cells. Besides, it was validated by dual-luciferase assay in which miR-224-5p directly targeted OCLN gene. The expression of OCLN was downregulated in ccRCC cells, and overexpression of miR-224-5p could inhibit the mRNA and protein expression levels of OCLN. Overexpression of OCLN could reduce the proliferation, migration, and invasion of ccRCC cells, while overexpressed miR-224-5p could partially reverse that inhibitory effect. Therefore, the promotive effect of miR-224-5p on the proliferation, invasion, and migration of ccRCC cell lines was at least partly due to the inhibition of OCLN expression. These findings highlighted the important function of miR-224-5p, which was promoting cell proliferation, migration, and invasion by downregulating OCLN, in the pathogenesis of ccRCC, and provided a potential treatment strategy.
References
1.
Hsieh
JJ
, Purdue
MP
, Signoretti
S
, Swanton
C
, Albiges
L
, Schmidinger
M
, Renal cell carcinoma
. Nat Rev Dis Primers
. 2017
;3
:17009
. .2.
Rossi
SH
, Klatte
T
, Usher-Smith
J
, Stewart
GD
. Epidemiology and screening for renal cancer
. World J Urol
. 2018
;36
(9
):1341
–53
. .3.
Nabi
S
, Kessler
ER
, Bernard
B
, Flaig
TW
, Lam
ET
. Renal cell carcinoma: a review of biology and pathophysiology
. F1000Res
. 2018
;7
:307
. .4.
Nerich
V
, Hugues
M
, Paillard
MJ
, Borowski
L
, Nai
T
, Stein
U
, Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
. Onco Targets Ther
. 2014
;7
:365
–74
. .5.
Diaz de Leon
A
, Pedrosa
I
. Imaging and screening of kidney cancer
. Radiol Clin North Am
. 2017
;55
(6
):1235
–50
. .6.
Chen
G
, Lu
L
, Liu
C
, Shan
L
, Yuan
D
. MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma
. PLoS One
. 2015
;10
(3
):e0117714
. .7.
Jansson
MD
, Lund
AH
. MicroRNA and cancer
. Mol Oncol
. 2012
;6
(6
):590
–610
. .8.
Li
M
, Wang
Y
, Song
Y
, Bu
R
, Yin
B
, Fei
X
, MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review)
. Oncol Rep
. 2015
;33
(4
):1571
–8
. .9.
Lin
S
, Gregory
RI
. MicroRNA biogenesis pathways in cancer
. Nat Rev Cancer
. 2015
;15
(6
):321
–33
. .10.
Jingushi
K
, Ueda
Y
, Kitae
K
, Hase
H
, Egawa
H
, Ohshio
I
, miR-629 targets TRIM33 to promote TGFβ/smad signaling and metastatic phenotypes in ccRCC
. Mol Cancer Res
. 2015
;13
(3
):565
–74
. .11.
Zhai
W
, Ma
J
, Zhu
R
, Xu
C
, Zhang
J
, Chen
Y
, MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis
. Br J Cancer
. 2018
;119
(5
):591
–604
. .12.
Xu
X
, Wu
J
, Li
S
, Hu
Z
, Xu
X
, Zhu
Y
, Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway
. Mol Cancer
. 2014
;13
:109
. .13.
Chen
X
, Wang
X
, Ruan
A
, Han
W
, Zhao
Y
, Lu
X
, miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression
. Clin Cancer Res
. 2014
;20
(10
):2617
–30
. .14.
Zheng
SQ
, Qi
Y
, Wu
J
, Zhou
FL
, Yu
H
, Li
L
, CircPCMTD1 acts as the sponge of miR-224-5p to promote glioma progression
. Front Oncol
. 2019
;9
:398
. .15.
Li
J
, Liu
X
, Li
C
, Wang
W
. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma
. J Cell Biochem
. 2019
;120
(8
):12412
–21
. .16.
Shi
L
, Xiao
W
, Liu
Z
, Pan
B
, Xu
Y
. Diet change of hadal amphipods revealed by fatty acid profile: a close relationship with surface ocean
. Mar Environ Res
. 2018
;142
:250
–6
. .17.
Zang
CS
, Huang
HT
, Qiu
J
, Sun
J
, Ge
RF
, Jiang
LW
. MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma
. Eur Rev Med Pharmacol Sci
. 2020
;24
(9
):4890
–900
. .18.
Zhao
H
, Bi
T
, Qu
Z
, Jiang
J
, Cui
S
, Wang
Y
. Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma
. Oncol Rep
. 2014
;32
(3
):1003
–12
. .19.
Sendi
H
, Mehrab-Mohseni
M
, Foureau
DM
, Ghosh
S
, Walling
TL
, Steuerwald
N
, MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA
. Liver Int
. 2015
;35
(4
):1315
–23
. .20.
Wang
K
, Sun
Y
, Tao
W
, Fei
X
, Chang
C
. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals
. Cancer Lett
. 2017
;394
:1
–12
. .21.
Zhang
L
, Huang
LS
, Chen
G
, Feng
ZB
. Potential targets and clinical value of MiR-224-5p in cancers of the digestive tract
. Cell Physiol Biochem
. 2017
;44
(2
):682
–700
. .22.
Zhang
CZ
. Long non-coding RNA FTH1P3 facilitates oral squamous cell carcinoma progression by acting as a molecular sponge of miR-224-5p to modulate fizzled 5 expression
. Gene
. 2017
;607
:47
–55
. .23.
Furuse
M
, Hirase
T
, Itoh
M
, Nagafuchi
A
, Yonemura
S
, Tsukita
S
, Occludin: a novel integral membrane protein localizing at tight junctions
. J Cell Biol
. 1993
;123
(6 Pt 2
):1777
–88
. .24.
Balda
MS
, Whitney
JA
, Flores
C
, González
S
, Cereijido
M
, Matter
K
. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein
. J Cell Biol
. 1996
;134
(4
):1031
–49
. .25.
Balda
MS
, Flores-Maldonado
C
, Cereijido
M
, Matter
K
. Multiple domains of occludin are involved in the regulation of paracellular permeability
. J Cell Biochem
. 2000
;78
(1
):85
–96
. .26.
Orban
E
, Szabo
E
, Lotz
G
, Kupcsulik
P
, Paska
C
, Schaff
Z
, Different expression of occludin and ZO-1 in primary and metastatic liver tumors
. Pathol Oncol Res
. 2008
;14
:299
–306
.27.
Tobioka
H
, Isomura
H
, Kokai
Y
, Tokunaga
Y
, Yamaguchi
J
, Sawada
N
. Occludin expression decreases with the progression of human endometrial carcinoma
. Hum Pathol
. 2004
;35
(2
):159
–64
. .28.
Jacob
P
3rd, Lewis
ER
, Elias-Baker
BA
, Jones
RT
. A pyrolysis product, anhydroecgonine methyl ester (methylecgonidine), is in the urine of cocaine smokers
. J Anal Toxicol
. 1990 Nov
;14
(6
):353
–7
. .29.
Xia
M
, Wei
J
, Tong
K
. MiR-224 promotes proliferation and migration of gastric cancer cells through targeting PAK4
. Pharmazie
. 2016
;71
(8
):460
–4
. .30.
Li
S
, Zhang
J
, Zhao
Y
, Wang
F
, Chen
Y
, Fei
X
. miR-224 enhances invasion and metastasis by targeting HOXD10 in non-small cell lung cancer cells
. Oncol Lett
. 2018
;15
(5
):7069
–75
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
